Equities

Electromed Inc

Electromed Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)20.29
  • Today's Change-0.21 / -1.02%
  • Shares traded99.96k
  • 1 Year change+97.57%
  • Beta0.2598
Data delayed at least 15 minutes, as of Sep 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.

  • Revenue in USD (TTM)54.72m
  • Net income in USD5.15m
  • Incorporated1992
  • Employees174.00
  • Location
    Electromed Inc500 6th Ave NWNEW PRAGUE 56071United StatesUSA
  • Phone+1 (952) 758-9299
  • Websitehttps://smartvest.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
908 Devices Inc.52.69m-37.99m133.08m230.00--0.8505--2.53-1.15-1.151.604.520.25111.544.95229,069.60-18.11-14.16-20.12-15.3552.3253.02-72.10-64.254.23--0.00--7.2117.89-8.45--22.98--
InfuSystem Holdings Inc129.37m366.00k136.42m499.00408.682.5510.891.050.01570.01575.992.511.2210.386.44259,264.500.34654.600.4015.6949.6856.430.28294.071.641.970.38980.0014.4413.384,744.44--6.01--
Akoya Biosciences Inc93.22m-60.35m144.04m330.00--6.47--1.55-1.22-1.221.890.44980.56051.936.34282,472.70-36.29---45.98--57.57---64.74--1.98-8.000.7755--29.09--10.36------
Acme United Corp192.71m19.45m157.55m645.008.581.526.300.81764.974.9748.5928.131.152.074.83298,770.5011.607.0913.798.2939.4035.7210.095.501.776.600.262118.81-1.276.88486.3131.089.024.84
Stereotaxis Inc23.75m-22.08m169.31m122.00--14.62--7.13-0.265-0.2650.2850.2020.56321.145.04194,639.30-49.21-25.02-71.93-34.1259.2867.57-87.38-41.901.53--0.00---4.89-1.82-12.33--6.63--
Semler Scientific Inc61.74m15.82m171.10m92.0012.042.1810.382.772.032.037.9311.220.770616.269.15671,097.8019.7438.8322.0044.4188.6790.2225.6232.583.66--0.00--20.2825.9843.6932.64-0.3821--
Electromed Inc54.72m5.15m177.10m174.0035.403.9829.563.240.57910.57916.175.161.123.272.25314,459.8010.518.6412.5110.0976.2676.269.418.065.27--0.000.0013.8311.8262.6721.06-22.23--
Trubridge Inc336.56m-52.28m183.71m3.22k--1.01--0.5459-3.68-3.6823.6412.120.7947196.765.88104,553.30-12.661.25-14.341.4148.7050.40-15.931.561.760.61150.498545.063.913.89-387.73--88.71--
Accuray Inc446.55m-15.55m188.56m1.02k--4.18--0.4223-0.1596-0.15964.530.45430.94232.145.36---3.28-1.37-5.61-2.3332.0536.42-3.48-1.550.9470.37570.7925---0.23551.29-67.51------
Senseonics Holdings Inc24.04m-80.46m196.82m132.00--340.34--8.19-0.1323-0.13230.03950.07140.18152.585.99182,113.60-60.74-73.65-74.52-106.9712.04-40.41-334.69-649.862.89-10.930.5802--36.623.43-142.49---18.76--
Orchestra Biomed Holdings Inc2.08m-55.58m200.47m56.00--4.30--96.43-1.57-1.570.05861.230.0211.3416.5737,125.00-56.06---64.66--92.02---2,673.26--4.58--0.00---21.88---37.91------
CVRx Inc44.39m-54.39m201.52m200.00--3.64--4.54-2.57-2.572.102.540.42090.62535.79221,965.00-51.56---56.39--84.40---122.52--8.85-18.480.3467--74.89--0.5528------
Neuropace Inc71.82m-29.90m215.77m171.00--21.78--3.00-1.09-1.092.610.33920.73051.746.49419,994.20-30.41---34.66--74.15---41.63--5.47-4.370.8565--43.72--30.00------
Nevro Corp426.10m-77.44m218.11m1.22k--0.7936--0.5119-2.12-2.1211.697.370.72661.115.93350,697.90-13.21-13.64-15.59-16.6868.0668.54-18.18-20.673.53-28.950.4433--4.631.88-3,172.74--0.9012--
LifeMD Inc178.28m-26.60m227.40m207.00------1.28-0.7004-0.70044.70-0.1013.596.8638.19861,255.40-44.31-153.05-333.96-526.9188.9283.66-12.34-45.440.8327-8.191.13--28.1578.9051.27--143.64--
Data as of Sep 21 2024. Currency figures normalised to Electromed Inc's reporting currency: US Dollar USD

Institutional shareholders

26.34%Per cent of shares held by top holders
HolderShares% Held
Summers Value Partners LLCas of 14 Dec 2023550.49k6.37%
The Vanguard Group, Inc.as of 30 Jun 2024365.31k4.23%
Punch & Associates Investment Management, Inc.as of 30 Jun 2024349.44k4.05%
Dimensional Fund Advisors LPas of 30 Jun 2024264.88k3.07%
Acadian Asset Management LLCas of 30 Jun 2024214.10k2.48%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Dec 2023126.22k1.46%
GAMCO Asset Management, Inc.as of 30 Jun 2024125.00k1.45%
Renaissance Technologies LLCas of 30 Jun 2024103.00k1.19%
Hunter Associates Investment Management LLCas of 30 Jun 202491.20k1.06%
Bridgeway Capital Management LLCas of 30 Jun 202486.16k1.00%
More ▼
Data from 05 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.